Device

Part:BBa_K302018:Experience

Designed by: Steven Woodhouse, Alan Koh, Rachel May Boyd, Philip Hall   Group: iGEM10_Newcastle   (2010-08-18)
Revision as of 03:45, 26 September 2022 by SinubilovesCola (Talk | contribs) (User Reviews)


This experience page is provided so that any user may enter their experience using this part.
Please enter how you used this part and how it worked out.

Applications of BBa_K302018

User Reviews

UNIQ53a6d4cf227040e8-partinfo-00000000-QINU UNIQ53a6d4cf227040e8-partinfo-00000001-QINU

User Reviews

Liaoliao_Gao
In 2022, ZJU-China iGEM team has characterized the output of this part in a novel chassis E. coli BL21(DE3). The result was documented in the experience page and the main page of (BBa_K302018).

Contribution from iGEM2022 ZJU-China

The sequence of (BBa_K302018) was synthesized and cloned into the PHY-plasmid to obtain the recombinant expression vector

We first tested the inhibitory concentration of subtilisin by zone of inhibition experiment, using BL21 transformed by PHY-Immunity plasmid or PHY-Empty plasmid as control. The concentration of subtilisin were 100mg/ml, 50mg/ml, 25mg/ml, 12.5mg/ml.

GLL-2.png
Fig1 Zone of inhibition experiment for subtilisin in BL21.